Women managing PCOS, perimenopause, postpartum hormone shifts, or unexplained low libido need a primary care model built around repeat bloodwork and a physician who reads the results, not a ten-minute visit that treats each symptom as a separate problem.
TL;DR
- Direct primary care womens health under GoodLife Health means hormone and thyroid panels every 90 days for one flat $299/month fee.
- Perimenopause and PCOS are Strong fit scenarios because both need repeat labs, not a single annual physical.
- Low libido and low testosterone in women get lab-confirmed dosing instead of a guess based on symptoms alone.
- Skip a same-day walk-in clinic if what you actually need is continuity across cycles, not a one-off visit.
Why this matters
PCOS, perimenopause, and postpartum hormone shifts do not show up on a single lab draw. Estradiol, progesterone, testosterone, and thyroid markers move on a cycle, and a single annual TSH test misses most of what is actually changing.
Insulin resistance compounds the problem. A woman with PCOS can have normal fasting glucose and still be insulin resistant, which is why fasting insulin belongs on the same panel as HbA1c, not treated as an optional add-on.
Direct primary care womens health works when the model is built around this reality: quarterly labs, a physician who reads them before prescribing anything, and continuity between the metabolic side (weight, insulin, lipids) and the reproductive side (estrogen, progesterone, testosterone, thyroid). Treat them as two systems and you end up chasing symptoms for years.
Who this is for
This is for women in their 30s through 50s dealing with PCOS, perimenopause symptoms, postpartum hormone and weight changes, or low libido that an insurance-based visit dismissed after one bloodwork panel. It is also for anyone who wants quarterly hormone tracking instead of an annual physical that checks a box and moves on.
What to look for in direct primary care for women's reproductive health
Full hormone and thyroid panels, not just TSH
A single TSH test misses free T3, free T4, and thyroid antibodies, all of which affect cycle regularity and energy. A Cardiometabolic Optimization Membership bundles full thyroid and hormone panels into the same quarterly Biomarker Audit, so nothing gets checked in isolation.
A physician who reads labs before prescribing anything
Algorithmic telehealth platforms often issue a prescription off a symptom questionnaire. That is backwards for hormone therapy, where dosing without a baseline lab is a guess dressed up as a prescription.
Metabolic and reproductive health tracked together
PCOS is as much an insulin problem as an ovarian one. A doctor who only orders a pelvic ultrasound and skips fasting insulin is missing half the picture.
Bioidentical hormone options without markup
Estrogen, progesterone, and testosterone dosing should adjust based on labs, not on what a clinic marks up the most. Under GoodLife Health's model, medications bill at pharmacy cost with no molecule or dose upcharge.
Quarterly retesting, not an annual physical
Hormone levels shift across a cycle and across months of therapy. One test a year cannot catch a dose that stopped working in month four.
Branded GLP-1 access without the compounded-pharmacy gamble
Women with PCOS often carry both reproductive and metabolic symptoms, and weight loss support matters for both. FDA-approved options like Wegovy, Zepbound, and Ozempic have trial data behind them (roughly 15% average weight loss in the STEP-1 trial for semaglutide); compounded copies do not carry that same evidence base.
Top picks by scenario
Perimenopause hormone optimization — the most common reason women in their 40s join a membership like this. Estradiol and progesterone shifts during perimenopause drive sleep, mood, and weight changes that a single annual panel will not catch across a 90-day window. Hormone optimization for women in perimenopause covers what a lab-guided protocol looks like. Strong fit.
PCOS and insulin resistance — the metabolic-reproductive overlap that most primary care visits split into two separate referrals. Fasting insulin, HbA1c, and androgen panels need to be read together, not chased one symptom at a time. Weight loss for women with PCOS walks through what actually moves the needle. Strong fit.
Low libido and low testosterone in women — the symptom most insurance visits wave off as stress or aging. Free and total testosterone both belong on the panel before anyone prescribes anything. Testosterone therapy for women with low libido covers what labs justify treatment. Strong fit.
Postpartum hormone and weight recovery — thyroid and hormone panels shift for months after delivery, and a six-week postpartum checkup rarely retests past that point. A quarterly cadence catches what a single visit misses. Consider, especially past the six-month mark when symptoms persist.
General preventive hormone screening in your 30s — no symptoms yet, but a baseline before perimenopause hits gives you something to compare against later. Consider, mainly for women who want a lab history started early rather than waiting for symptoms to force the issue.
What to avoid
- Compounded semaglutide or tirzepatide platforms with no lab monitoring. These skip the baseline panels that catch insulin resistance or thyroid issues driving your symptoms in the first place, and compounded GLP-1 copies carry a different safety profile than the FDA-approved originals.
- Peptide-driven med spa hormone protocols. Dosing without a physician reading quarterly labs is guesswork, regardless of how the clinic markets it.
- Insurance visits that run one TSH and call it complete. A single thyroid marker misses free T3, free T4, and antibodies, all of which matter for cycle regularity and energy.
Verdict comparison
| Scenario | Core labs tracked | Retest cadence | Verdict |
|---|---|---|---|
| Perimenopause | Estradiol, progesterone, thyroid panel | 90 days | Strong fit |
| PCOS and insulin resistance | Fasting insulin, HbA1c, androgens | 90 days | Strong fit |
| Low libido / low testosterone | Free and total testosterone | 90 days | Strong fit |
| Postpartum recovery | Thyroid panel, hormone panel | 90 days | Consider |
| Baseline screening (30s, no symptoms) | Full hormone and metabolic panel | 90 days | Consider |
FAQ
What's the best direct primary care option for women's reproductive health in 2026?
The strongest options in 2026 combine a flat membership fee with quarterly hormone and thyroid panels rather than a single annual physical. GoodLife Health's Cardiometabolic Optimization Membership runs $299 a month after a $598 two-month start and bundles a full Biomarker Audit every 90 days.
Is direct primary care worth it for PCOS management?
Yes, if the membership tracks fasting insulin and androgens alongside weight, since PCOS is as much a metabolic condition as a reproductive one. A single pelvic ultrasound without insulin markers misses half the picture.
How much does a direct primary care membership cost for women's hormone care?
GoodLife Health charges $598 for the first two months, then $299 a month flat, with no separate charge for the quarterly Biomarker Audit. Additional labs outside the 90-day cadence bill at pass-through cost.
Can a direct primary care doctor prescribe hormone therapy for perimenopause?
Yes, licensed physicians can prescribe estrogen, progesterone, and testosterone for perimenopause once baseline labs confirm the need. Under GoodLife Health's model, clinicians of Beluga Health, P.A. order the labs and adjust dosing from the results, not from a symptom checklist alone.
Is bioidentical hormone therapy included in the membership?
Bioidentical hormone options are prescribed as part of the same flat $299 monthly fee, with medications billed at pharmacy cost. There is no markup on the molecule or the dose.
How often are hormone labs run under the membership?
A comprehensive Biomarker Audit runs every 90 days, four times a year, covering hormone, thyroid, and metabolic markers together. That cadence catches dose adjustments an annual physical would miss.
Does the membership cover GLP-1 medications for PCOS-related weight gain?
Branded, FDA-approved GLP-1 medications like Wegovy, Zepbound, Ozempic, and Mounjaro are available when labs support the prescription, billed at pharmacy cost with no markup. Compounded GLP-1 copies are never part of the model.
What's the difference between direct primary care and a med spa for hormone therapy?
Direct primary care ties hormone dosing to repeat labs read by a licensed physician, while many med spas prescribe off a symptom form without retesting. The difference shows up at the second visit, when one model adjusts dose based on new numbers and the other just refills the same prescription.
One last thing
PCOS affects roughly 1 in 10 women of reproductive age, and insulin resistance drives as much of it as ovarian hormones do — which is exactly why a fasting insulin marker belongs on the same 90-day panel as your estradiol and thyroid numbers, not a separate referral six months later.
Related guides
References
- Direct Primary Care: Practice Distribution and Cost Across the Nation (J Am Board Fam Med). 2015. pubmed.ncbi.nlm.nih.gov/26546651/